BASE4 Biosciences
PrivateLast Round
Pre Seed
Apr 22, 2026
Total Funding Raised
$1M
Company Overview
BASE4 Biosciences is a biotech company that has developed a multi-omic platform using AI to analyze gene expression from a blood sample to determine the biological age of tissues and detect early signs of disease, with an initial focus on women's health.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BASE4 Biosciences Comps
Public and private peers based on sector, stage, and business model.
BASE4 Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 22, 2026 |
BASE4 Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Itnig | Pre Seed |
| Kfund | Pre Seed |
| Baobab Ventures | Pre Seed |
| Masia | Pre Seed |
| K Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
$1M raised in Pre Seed round.
BASE4 Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BASE4 Biosciences's valuation, stock price, and market status.